FDA 505(b)(2) Applications Seminar Part VIII: Q&A and Discussion of 505(b)(2) Applications

Posted by

Regis Technologies, Inc.

Regis Technologies hosted a seminar on FDA 505(b)(2) Applications in March 2016. Two guest speakers from PAREXEL Consulting, Aloka Srinivasan, Ph.D., and Partha Roy, Ph.D., delivered excellent information and led an engaging discussion on this convenient New Drug Application (NDA) approval pathway for the pharmaceutical industry. Conclude the seminar with this very engaging discussion between our guests and both speakers.